Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLI400 Laxative in Constipated Adults
NCT02819297Phase 3Completed
- Sponsor
- Braintree Laboratories
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic idiopathic constipation (CIC) comparing BLI400 Laxative with Placebo (2 arms). Primary endpoint: Treatment Response at 12 weeks. Started Jun 2016; status: completed.
02
Drugs
lactitol
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT02819297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819297.